1. United States
2. Kan.
3. Letter

In early 2025, after Extremity Care, a company that sells overpriced medical bandages with no proven effectiveness, donated five million dollars to the Trump Super PAC, President Trump swiftly froze a Biden-era regulatory action that would have limited Medicare from overpaying for these products. These bandages cost as much as $11,000 per square inch while Medicare has rapidly spent over ten billion dollars in one year on such substitutes, more than on ambulance rides or CT scans. This isn’t healthcare reform, it’s favoritism disguised as policy. Medicare was set to institute a rule that would only cover skin substitute products backed by rigorous research. That’s a rule rooted in both fiscal responsibility and medical integrity. Instead, the rule was delayed. Medicare now spends billions on products with little evidence of benefit. Meanwhile, there are significantly cheaper options, hundreds or even thousands of dollars per square inch, that have demonstrated effectiveness. This delay doesn’t help patients. It helps donors. We demand action. Launch an immediate investigation into the role political contributions played in this policy reversal. Hold hearings. Tighten Medicare oversight. Congress must send a clear message: public health cannot be bought. We will protect science, truth, and the health of Americans, even if it steps on powerful toes.